window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 16, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Machine Learning

  • Artificial Intelligence,Biotech,Drug Development,Partnerships & Funding,Research & Development,Technology and platforms

    Nuclera and leadXpro partner on AI-guided workflow for membrane protein drug discovery

    Nuclera and leadXpro have entered a scientific partnership to develop [...]

    February 17, 2026
  • Artificial Intelligence,Clinical Trials,Data Management

    Six geese a-laying: CluePoints’ AI predictions for 2026

    As our Christmas countdown continues, we move from reflections on [...]

    December 18, 2025
  • Artificial Intelligence,Data Management,Market Access & Commercialization,Technology and platforms

    Veeva’s Sebastian Wurst on building the data foundation for enterprise AI

    The promise of AI in commercial biopharma is immense, with [...]

    November 7, 2025
  • Artificial Intelligence,Biomanufacturing,Digital Health,Drug Development,Technology and platforms

    The path to the autonomous lab: balancing innovation, culture, and compliance

    Laboratories across the pharmaceutical industry are moving closer to full [...]

    October 16, 2025
  • Artificial Intelligence,Clinical Development,Digital Health,Drug Development

    New AI tool offers real-time insights into clinical trial participant behavior

    Cognivia has launched Cognivia Signal, an AI-powered platform designed to [...]

    October 12, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Drug Development,Precision medicine,Research & Development

    Latent Labs unveils AI model Latent-X for instant, lab-validated protein binder design

    No-code platform opens early access to generative binder design with [...]

    August 1, 2025
  • Clinical Development,Clinical Trials,Patient Centricity,Technology and platforms

    Linus Health to showcase AI tools for brain health detection and trial recruitment at AAIC 2025

    Linus Health will present new findings on its AI-driven cognitive [...]

    July 23, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Cell & Gene Therapy,Clinical Development

    Shift Bioscience tackles AI model flaws to advance rejuvenation discovery

    New study proposes AI-driven framework to refine gene target discovery [...]

    July 4, 2025
  • Artificial Intelligence,Drug Development,Technology and platforms

    Optibrium and TalTech launch EU-funded PhD to advance sustainable drug discovery

    Partnership aims to boost predictive metabolism models using machine learning [...]

    July 2, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Drug Development,Technology and platforms

    AI can’t thrive in chaos: New survey finds labs still struggling with basics

    A new industry survey has revealed that while life sciences [...]

    June 27, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board
    Categories: Artificial Intelligence, Biotech, Drug Development, Drug discovery, Research & Development
  • Weite Oldenziel
    Ofichem unifies CDMO and pharmaceutical supply brands under single identity
    Categories: CDMOs & Manufacturing, Supply Chain & Logistics
  • DeepCyte raises $1.5M to advance single-cell AI toxicology platform for drug development
    Categories: Artificial Intelligence, Drug discovery, Funding, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top